Protecting Health. Strengthening Canada’s Preparedness.

For 50 years, the Vaccine and Infectious Disease Organization (VIDO) has helped protect people, animals, and economies from infectious diseases. Through vaccine development, high-containment research, and global partnerships, VIDO translates science into real-world solutions.

Advanced a COVID-19 vaccine to Phase 2 human clinical trials
50+ years of developing solutions to infectious disease threats
100+ years of executive management experience on leadership team
Developed 60+ animal models used for developing new medicines

VIDO's Impact

a woman inserts a needle into a man's arm

Protecting public health

VIDO develops vaccines and countermeasures to emerging infectious diseases, helping Canada respond quickly to future health threats.

Related stories

a dairy cow

Supporting Food Security

VIDO’s research protects livestock and wildlife from disease, supporting food security and Canada’s agricultural economy.

Related stories
a technician in white PPE works on a machine

Strengthening Canada’s Sovereignty & Readiness

VIDO’s advanced containment facilities and scientific expertise give Canada the capacity to study high-risk pathogens and develop solutions.

Related stories

Global Parnerships

VIDO collaborates with governments, industry, and research organizations around the world to accelerate vaccine and therapeutic development.

world map with dots to indicate location of partners
Canadian Food Inspection Agency (CFIA) / Public Health Agency of Canada (PHAC)
  • MOUs with both CFIA and PHAC
  • Collaborations on SARS-CoV-2, ASF and HPAI (cattle)
  • Emergency and surge backup for Government of Canada
Coalition for Epidemic Preparedness Innovations (CEPI)
  • Only Canadian academic institution to be awarded direct CEPI funding
  • 9th CEPI Preclinical Network selected globally
  • Selected as part of the CEPI Adjuvant Network

INTERCEPTOR

  • Joined global network of 19 high-containment labs to strengthen pandemic preparedness
  • Leveraging CL3–CL4 capabilities and vaccine expertise to advance coordinated international response

International Livestock Research Institute (ILRI) / Kenya Agricultural & Livestock Research Organization (KALRO)

  • Developed contagious bovine pleuropnemonia prototype vaccine
  • Historic training exchanges
  • Expanding partnership into new areas
International Vaccine Institute (IVI)
  • Longstanding global health partnership
  • Tuberculosis identified as a priority vaccine project
  • Supported Canada joining IVI as a member country
NATO DIANA
  • Awarded Canada’s only biotech-focused test centre
  • Expanding role in defence-related research
  • Increasing international visibility
The Pirbright Institute
  • Active collaboration on ASF and B-cell repertoire research
  • Scientist and training exchanges
  • Partnering on vaccine manufacturing assets
Vaccine Formulation Institute (VFI)
  • Partnered on COVID-19 vaccine development
  • First use of SEPIVAC SWE adjuvant in humans
  • Expanding collaboration to include additional key adjuvants

Looking Ahead

Emerging infectious diseases continue to impact health systems, economies, and food security worldwide. By advancing research, training experts, and expanding national research infrastructure, VIDO is helping ensure Canada is ready for the next pandemic.